• Technology
  • Products
    • Automated System
    • HC Generator
    • On-Demand Analytics and Insights
  • Testing
    • Test Reports
    • Test Report Summaries
    • Real-World Efficacy Testing Guidelines
  • Environments
    • Commercial
    • Education
    • Entertainment
    • Government
    • Healthcare
    • Hospitality
    • New Construction
    • Residential
    • Senior Living
  • Resources
  • About Us
Contact
  • Technology
  • Products
    • Automated System
    • HC Generator
    • On-Demand Analytics and Insights
  • Testing
    • Test Reports
    • Test Report Summaries
    • Real-World Efficacy Testing Guidelines
  • Environments
    • Commercial
    • Education
    • Entertainment
    • Government
    • Healthcare
    • Hospitality
    • New Construction
    • Residential
    • Senior Living
  • Resources
  • About Us

Sample Charts of PuriFi PM Sensor Data & Trending

Laboratory Test Report

Loading...

University of Arizona Efficacy Testing on Pathogens and Microbials

Laboratory Test Report

Loading...

EPA Designed Aerobiology Chamber for Coronavirus Surrogates

EPA, Laboratory Test Report

Loading...

Coronavirus Aerosol Surrogate Neutralization Test

Coronavirus, Laboratory Test Report

Loading...

SARS-CoV-2 Surface Neutralization Test

Laboratory Test Report, SARS-CoV-2

Loading...

EPA’s First Round of Test Method Development Research

EPA, Laboratory Test Report

Loading...
« Older Entries
Next Entries »

Recent Posts

  • Real-World Efficacy Testing Guidelines
  • EPA Office of Research and Development releases interim data results from testing PuriFi against non-enveloped Virus MS2 in first round of test method development research.
  • PuriFi announces neutralization test results of airborne enveloped virus SARS-CoV-2 by BSL-3 laboratory, under real-world conditions.
  • PuriFi demonstrates 95% total airborne reduction of SARS-CoV-2 B.1.617.2 (Delta) Variant in 29 minutes, with a progressive reduction of 99.999% in 59 minutes*.
  • PuriFi demonstrates 92% total airborne reduction of SARS-CoV-2 B.1.1.529 (Omicron) Variant in 29 minutes, with a progressive reduction of 99.998% in 59 minutes*.

Recent Comments

No comments to show.
Real-World Efficacy Testing Guidelines

Testing Guidelines

Real-World Efficacy Testing Guidelines

Testing Guidelines